MicroRNA-30a contributes to pre-eclampsia through regulating the proliferation, apoptosis, and angiogenesis modulation potential of mesenchymal stem cells by targeting AVEN

References

• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.
   PubMed Web of Science ®Google Scholar
• Zhou CC, Zhang Y, Irani RA, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14(8):855–862.
   PubMed Web of Science ®Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
   PubMed Web of Science ®Google Scholar
• Ray JE, Garcia J, Jurisicova A, et al. Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia. Cell Death Differ. 2010;17(5):846–859.
   PubMed Web of Science ®Google Scholar
• Whitley GS, Dash PR, Ayling LJ, et al. Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia. Am J Pathol. 2007;170(6):1903–1909.
   PubMed Web of Science ®Google Scholar
• Macias MI, Grande J, Moreno A, et al. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol. 2010;203(5):495.e9-.e23.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defifining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Fehrer C, Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol. 2005;40(12):926–930.
   PubMed Web of Science ®Google Scholar
• James JL, Srinivasan S, Alexander M, et al. Can we fix it? Evaluating the potential of placental stem cells for the treatment of pregnancy disorders. Placenta. 2014;35(2):77–84.
   PubMed Web of Science ®Google Scholar
• Haddad R, Saldanha-Araujo F. Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? Biomed Res Int. 2014;2014:216806.
   PubMed Web of Science ®Google Scholar
• Wang LL, Yu Y, Guan HB, et al. Effect of human umbilical cord mesenchymal stem cell transplantation in a rat model of preeclampsia. Reprod Sci. 2016;23(8):1058–1070.
   PubMed Web of Science ®Google Scholar
• Meirelles Lda S, Fontes AM, Covas DT, et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5–6):419–427.
   PubMed Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol. 2003;188(1):177–182.
   PubMed Web of Science ®Google Scholar
• Cutler AJ, Limbani V, Girdlestone J. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol. 2010;185(11):6617–6623.
   PubMed Web of Science ®Google Scholar
• Brown C, McKee C, Bakshi S, et al. Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med. 2019;13(9):1738–1755.
   PubMed Web of Science ®Google Scholar
• Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod. 2007;22(11):2903–2911.
   PubMed Web of Science ®Google Scholar
• Seungil R, Chanjae P, David Y, et al. Tissue-dependent paired expression of miRNAs. Nucleic Acids Res. 2007;35(17):5944–5953.
   PubMed Web of Science ®Google Scholar
• Mallory AC, Vaucheret H. MicroRNAs: something important between the genes. Curr Opin Plant Biol. 2004;7(2):120–125.
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med. 2009;60(1):167–179.
   PubMed Web of Science ®Google Scholar
• Bussing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med. 2008;14(9):400–409.
   PubMed Web of Science ®Google Scholar
• Yao J, Liang L, Huang S, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting galphai2 in hepatocellular carcinoma. Hepatology. 2010;51(3):846–856.
   PubMed Web of Science ®Google Scholar
• Fredsøe J, Rasmussen AKI, Thomsen AR, et al. Diagnostic and prognostic microrna biomarkers for prostate cancer in cell-free urine. Eur Urol Focus. 2018;4(6):825–833.
   PubMedGoogle Scholar
• Anton L, Olarerin-George AO, Hogenesch JB, et al. Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia. PLoS ONE. 2015;10(3):e0122707.
   PubMed Web of Science ®Google Scholar
• Anton L, Olarerin-George AO, Schwartz N, et al. MiR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol. 2013;183(5):1437–1445.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Diao Z, Su L, et al. MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol. 2010;202(5):466.e1–7.
   Web of Science ®Google Scholar
• Li Q, Pan Z, Wang X, et al. MiR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia. Biochem Biophys Res Commun. 2014;453(1):57–63.
   PubMed Web of Science ®Google Scholar
• Bai Y, Yang YY, Yang HX, et al. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating actriia expression. PLoS ONE. 2012;7(6):e38875.
   PubMed Web of Science ®Google Scholar
• Bridge G, Monteiro R, Henderson S, et al. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood. 2012;120(25):5063–5072.
   PubMed Web of Science ®Google Scholar
• Mao L, Liu S, Hu LJ, et al. MiR-30 family: a promising regulator in development and disease. Biomed Res Int. 2018;2018:9623412.
   PubMed Web of Science ®Google Scholar
• Zeng RC, Zhang W, Yan XQ, et al. Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer. Med Oncol. 2013;30(1):477.
   PubMed Web of Science ®Google Scholar
• Zhou J, Gong G, Tan H, et al. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. Oncol Rep. 2015;33(6):2915–2923.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan H, Zhao G, et al. MiR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J. 2012;279(24):4510–4524.
   PubMed Web of Science ®Google Scholar
• Eguchi T, Watanabe K, Hara ES, et al. OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesenchymal stem cells. PLoS ONE. 2013;8(3):e58796.
   PubMed Web of Science ®Google Scholar
• Cui L, Shi Y, Zhou X, et al. A set of microRNAs mediate direct conversion of human umbilical cord lining-derived mesenchymal stem cells into hepatocytes. Cell Death Dis. 2013;4(11):e918.
   PubMedGoogle Scholar
• Niu ZR, Han T, Sun XL, et al. MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1. Am J Obstet Gynecol. 2018;218(2):249.e1–12.
   PubMed Web of Science ®Google Scholar
• Chau BN, Cheng EH, Kerr DA, et al. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell. 2000;6(1):31–40.
   PubMed Web of Science ®Google Scholar
• Kutuk O, Temel SG, Tolunay S, et al. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL. Eur J Cancer. 2010;46(13):2494–2505.
   PubMed Web of Science ®Google Scholar
• Han K-Y, Won Hwang J, Bae G-U, et al. Akt regulation of aven contributes to the sensitivity of cancer cells to chemotherapeutic agents. Mol Med Rep. 2015;11(5):3866–3871.
   PubMed Web of Science ®Google Scholar
• Long BD, Wan Y, Zhang SQ, et al. LncRNA XIST protects podocyte from high glucose-induced cell injury in diabetic nephropathy by sponging miR-30 and regulating AVEN expression. Arch Physiol Biochem. 2020;1–8. DOI:10.1080/13813455.2020.1854307.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhao G, Fan H, et al. Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-α expression. PLoS One. 2014;9(2):e88036.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan H, Zhao G, et al. miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J. 2012;279(24):4510–4524.
   PubMed Web of Science ®Google Scholar
• Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018;2018(6):469–471.
   Google Scholar
• Rahmé R. Assaying cell cycle status using flow cytometry. Methods Mol Biol. 2021;2267:165–179.
   PubMedGoogle Scholar
• Li G, Wu X, Sun P, et al. Dithiolation indolizine exerts viability suppression effects on A549 cells via triggering intrinsic apoptotic pathways and inducing G2/M phase arrest. Biomed Pharmacother. 2021;133:110961.
   PubMed Web of Science ®Google Scholar
• Hnasko TS, Hnasko RM. The western blot. Methods Mol Biol. 2015;1318:87–96.
   PubMedGoogle Scholar
• Clément T, Salone V, Rederstorff M. Dual luciferase gene reporter assays to study miRNA function. Methods Mol Biol. 2015;1296:187–198.
   PubMedGoogle Scholar
• Chen S, Zhao G, Miao H, et al. MicroRNA-494 inhibits the growth and angiogenesis-regulating potential of mesenchymal stem cells. FEBS Lett. 2015;589(6):710–717.
   PubMed Web of Science ®Google Scholar
• Kanasaki K, Kalluri R. The biology of preeclampsia. Kidney Int. 2009;76(8):831–837.
   PubMed Web of Science ®Google Scholar
• Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–2869.
   PubMed Web of Science ®Google Scholar
• Banek CT, Gilbert JS. Approaching the threshold for predicting preeclampsia: monitoring angiogenic balance during pregnancy. Hypertension. 2011;58(5):774–775.
   PubMed Web of Science ®Google Scholar
• Shi Y, Hu G, Su J, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 2010;20(5):510–518.
   PubMed Web of Science ®Google Scholar
• Ishii M, Shibata R, Numaguchi Y, et al. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler Thromb Vasc Biol. 2011;31(10):2210–2215.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Lee MJ, Seok OS, et al. Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. Cytokine. 2010;49(1):95–101.
   PubMed Web of Science ®Google Scholar
• Hsieh JY, Wang HW, Chang SJ, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013;8(8):e72604.
   PubMed Web of Science ®Google Scholar
• Chen ZR, Zhang W, Wu MY, et al. Pathogenic mechanisms of preeclampsia with severe features implied by the plasma exosomal mirna profile. Bioengineered. 2021 Dec;12(2):9140–9149.
   PubMed Web of Science ®Google Scholar
• Ji LQ, Zhang LP, Li YN, et al. MiR-136 contributes to pre-eclampsia through its effects on apoptosis and angiogenesis of mesenchymal stem cells. Placenta. 2017;50:102–109.
   PubMed Web of Science ®Google Scholar
• Wang YP, Fan HY, Zhao GF, et al. MiR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J. 2012;279(24):4510–4524.
   PubMed Web of Science ®Google Scholar
• Hu EL, Ding L, Miao HS, et al. MiR-30a attenuates immunosuppressive functions of IL-1b-elicited mesenchymal stem cells via targeting TAB3. FEBS Lett. 2015;589(24 Pt B):3899–3907.
   PubMed Web of Science ®Google Scholar
• Shyu MK, Chen CW, Lin NY, et al. MUC1 expression is elevated in severe preeclamptic placentas and suppresses trophoblast cell invasion via b1-integrin signaling. J Clin Endocrinol Metab. 2011;96(12):3759–3767.
   PubMed Web of Science ®Google Scholar